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outcomes after thoracic endoluminal aortic
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Frank R. Arko, MD, Dallas, Tex
Background: Thoracic endoluminal aortic aneurysm repair (TEVAR) is associated with improved outcomes compared with
open thoracic aortic aneurysm repair. This study was designed to better characterize TEVAR outcomes in a large population,
and to determine if outcomes are independently influenced by patient ethnicity and insurance status.
Methods: Using the Nationwide Inpatient Sample (NIS) database, we selected patients who underwent TEVAR between
2001 and 2005. Ethnicity and insurance type were independently evaluated against the outcome variables of mortality
and postoperative complications. Age, gender, hospital region, hospital location, hospital size, and comorbidities were
controlled as cofounders.
Results:Between 2001 and 2005, 875 patients underwent TEVAR. Therewas a significantly greater proportion of Caucasians
(n 650) compared with African Americans (n 104) or Hispanics (n 49). Patients had a male preponderance, and most
procedures were elective. The overall mortality was 13.3% (n  117), and spinal cord ischemia was 0.8% (n  7), with no
differences between patients of varied ethnicity or payer status. Significant differences were noted among the races including
gender (P  .003), income (P < .0001), hospital region (P < .001), hospital bed size (P  .013), and insurance type
(P < .001). Significant variations in demographics characteristics were also present between patients with different insurance
classifications including gender (P < .001), surgery type (P  .009), income (P  .003), race (P < .0001), and comorbidity
index (P < .0001). After adjustment for cofounders and multiple comparisons, there were no differences in rates of
complications among patients with varying race or insurance status.
Conclusions:Mortality after TEVAR remains high in the US, although this may be associated with its early introduction
during the study period. Nonetheless, the incidence of spinal cord ischemia is very low. Ethnicity and insurance type do
not appear to influence TEVAR outcomes. (J Vasc Surg 2010;51:14S-20S.)Thoracic aortic endoluminal repair (TEVAR) has been
widely accepted for the treatment of thoracic aneurysms.
Compared with standard open repair, TEVAR is associated
with improved surgical outcomes, including reduced short-
term morbidity and mortality and shorter hospital stays.1-4
These superior outcomes are likely secondary to avoidance
of thoracotomy, aortic cross-clamping, and excessive blood
loss, and have led to a rapid acceptance of this technology.
The number of patients presenting with thoracic aneu-
rysmal disease undergoing TEVAR can be expected to
increase as the population over age 65 continues to increase
in the United States. Estimates predict that Americans over
age 65 will increase from just over 40 million to nearly 89
million between 2010 and 2050. Further, the number of
minority patients presenting with thoracic aortic disease
From the Division of Vascular Surgery, University of Texas Southwestern
Medical Center.
Competition of interest: none.
Reprint requests: Frank R. Arko, MD, Chief, Endovascular Surgery, Asso-
ciate Professor, Division of Vascular & Endovascular Surgery, Depart-
ment of Surgery, UT Southwestern Medical Center, Dallas, TX 75390-
9157 (e-mail: frank.arko@utsouthwestern.edu).
The editors and reviewers of this article have no relevant financial relation-
ships to disclose per the JVS policy that requires reviewers to decline
review of any manuscript for which they may have a competition of
interest.
0741-5214/$36.00
Copyright © 2010 by the Society for Vascular Surgery.
doi:10.1016/j.jvs.2009.11.079
14Smay also be expected to increase. From 2010 to 2050, both
theHispanic and black populations are expected to increase
by 56% and 267%, respectively. By 2050, these estimates
predict that 10.5 million blacks and 17.5 million Hispanics
living in the US will be greater than 65 years old.5
Recent literature has highlighted concerns that ethnic-
ity influences outcomes following advanced medical and
surgical interventions. Numerous reports describe minority
status as an independent predictor of worse clinical out-
comes. These findings are poorly understood and may be
attributable to differing insurance statuses, limited access to
care, language barriers, provider bias, or differences in
perception of illnesses and management resulting in de-
layed care.6-20
Both ethnicity and payer status have been reported to
influence patient outcomes following endovascular repair of
the abdominal aorta.6-9 The goal of this study was to evaluate
the influence of insurance status and ethnicity on the out-
comes of thoracic endoluminal repair while controlling for
cofounders known to influence postoperative outcomes.
METHODS
Data source. Data was collected from the Nationwide
Inpatient Sample (NIS) database created as part of the
Healthcare Cost and Utilization Project (HCUP) by the
Agency for Healthcare Research and Quality (AHRQ).
The NIS is the largest encounter based, all-payer database
in the United States, including data from approximately 8
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provides 100% of their discharge data for each year of
inclusion. Overall, the NIS is designed to represent a 20%
stratified random sample of all hospital discharges each year
in the United States. For each hospital discharge, informa-
tion reported includes Diagnostic Related Groupings
(DRG), International Classification of Diseases, Ninth Re-
vision Clinical Modification (ICD-9-CM) codes, length of
stay, hospital and patient demographics, total charges, and
payer status. Patient demographics reported include gen-
der, age, ethnicity, andmedian income according to patient
zip code. Hospital demographics reported include region
of the country, size, and teaching status. Hospital size was
determined relative to other hospitals in the region so that
one-third of the hospitals in any one defined region were
categorized as small (1-200 beds), medium (25-450 beds),
and large (45-greater than 450 beds).21 Discharge status
was divided between discharge to home and non-routine
discharge, which included discharge to nursing home,
skilled nursing facility, or rehabilitation center. Payer status
was divided between Medicaid, Medicare, private insur-
ance, or other (private pay, uninsured, workers compensa-
tion, etc.).
Data collection. Patients selected for study included
those with ICD-9 diagnosis codes for thoracic aortic aneu-
rysm with (441.1) or without mention of rupture (441.2),
and a corresponding procedure code for thoracic endograft
implantation with or without branch vessel involvement
(39.73). Patients with diagnosis codes for aortic dissection
(441.00-441.03), thoracoabdominal aneurysm (441.6,
441.7), aneurysm of unspecified site (441.5, 441.9), or
with diagnostic or procedural codes for concomitant ab-
dominal aortic aneurysms (441.3, 441.4, 0.930) were ex-
cluded from this investigation. Patients were additionally
excluded if procedure codes were used to indicate endovas-
cular or open abdominal aortic aneurysm repair (39.71,
384.4), open thoracic aneurysm repair (384.5), excision of
blood vessels (38), resection with anastomosis of thoracic
or abdominal arteries (38), repair of thoracic or abdominal
arteries with tissue or synthetic patch grafts (38), or arterial
bypasses (39.22, 39.23, 39.26). Finally, patients were also
excluded if they were missing essential information, includ-
ing insurance status or ethnicity.
For each patient included in our investigation, we
collected patient demographics (age, race, gender), patient
comorbidities, DRGs, ICD-9 codes, hospital demograph-
ics (size, region), postoperative complications, postopera-
tive mortality, and discharge status. Patient comorbidities
were calculated according to Deyo classification, which
separates patients by the use of ICD-9 codes into three
groups (0, 1, 1), with higher numbers representing a
greater number of preoperative comorbidities.22 Postoper-
ative complications reviewed included: spinal cord isch-
emia, central nervous system complications, respiratory
complications, pneumonia, intubation, myocardial infarc-
tion, renal failure, implant complications, transfusions, and
postoperative infections.Data analysis. Statistical analyses were performed
with SPSS V.9 (SPSS Inc, Chicago, IL). Differences in
descriptive characteristics between the various races and
payer statuses were evaluated using a Pearson 2 model. A
Fisher exact test was used to assess the frequency of com-
plications between the races and differing insurances. A
Bonferroni correction (alpha/n, with alpha 0.05 and n
20) was used for each variable analyzed (insurance and
race), yielding P  .002 as the threshold for statistical
significance.
Logistic regression models were used to determine the
odds ratios for each postoperative outcome separated out
by race and insurance status. In both logistic regression
models, we corrected for possible cofounding variables
including age, gender, hospital location, hospital region,
Deyo classification, race when insurance status was exam-
ined, and insurance status when race was examined. A
Bonferroni correction (alpha/n, with alpha 0.05 and n
60) was again applied for each variable tested (insurance
and race), yielding P .0008 as the threshold for statistical
significance.
RESULTS
Patient characteristics. Between 2001 and 2005, a
total of 875 patients were recorded in the NIS database as
having undergone endoluminal repair of the thoracic aorta.
There was a male predominance of patients (67.3%). Most
procedures were elective, with 36.2% performed urgently
or emergently. The overall mortality was 13.3% (n 117).
Only 43.7% of survivors were discharged directly to home,
with the remaining patients transferred first to rehabilita-
tion centers, skilled nursing facilities, or nursing homes.
Spinal cord ischemia was low at only 0.8% (n  7).
Race. Descriptive characteristics are depicted in Table I.
The majority of patients were Caucasian (74.3%), with a
smaller number of minorities represented including Blacks
(11.9%), Hispanics (5.6%), and those classified as other
races (8.2%).
Significant differences existed among the races in gen-
der (P  .003), income (P  .001), region of the country
(P  .001), bed size of treating hospital (P  .013), and
insurance status (P  .001). There was a trend toward a
higher number of emergent operations in the black and
Hispanic populations, but this was not statistically signifi-
cant. Patients were matched by comorbidities according to
Deyo classification (Table II).
The unadjusted bivariate analysis of outcomes after
TEVAR revealed significant differences among the races in
terms of infection rate and other complications (Table II).
Further, after correcting for cofounding variables, includ-
ing insurance status, logistic regression analyses demon-
strated that white patients had a 3.41-fold increased risk of
infection compared with black patients (Table III). How-
ever, when the Bonferroni correction was applied to ac-
count for the presence of multiple variables, significant
variations between the races were eliminated in both biva-
riate and logistic regression analyses, indicating that these
differences were likely accountable to chance.
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rated by insurance type are listed in Table IV. The most
common payer statuses encountered included Medicare
(56.1%) and those with private insurance (33.0%), with a
smaller proportion of patients with Medicaid (5.4%) and
other classifications (5.5%; P  .001).
Significant differences in patient demographics were
noted among patients with differing insurance statuses in
terms of gender (P .001), race (P .001), comorbidities
according to Deyo classification (P  .001), income (P 
.003), and urgency of intervention (P  .009). TEVAR
was performed urgently or emergently in 61.7% of Med-
icaid patients, compared with 49.8% of private patients
and 32.6% of Medicare patients. There were no differ-
ences detected in region or bed size of treating hospital
(Table IV).
Again, unadjusted analyses of outcomes after TEVAR
revealed significant differences in terms of the incidence of
non-routine discharge and acute intestinal vascular insuffi-
ciency (Table V). Logistic regression modeling corrected
for the presence of cofounding variables including race
further demonstrated that Medicaid patients were signifi-
cantly one-third less likely to be intubated compared with
privately insured patients (Table VI). However, when the
Bonferroni correction for multiple variables was again ap-
plied, differences in outcomes among patients of differing
payer statuses were eliminated, indicating that these differ-
Table I. Demographic variations between
race classifications
Variable White Black Hispanic Other P-value
Total 650 104 49 72
Gender .00
Male 450 54 32 53
Surgery type .11
Emergent 148 37 16 11
Urgent 84 15 1 5
Elective 319 42 20 26
Income .00
$1K-36K 139 41 9 19
$36K-45K 132 26 20 10
$45K 362 32 17 39
Hospital region .00
Northeast 190 25 8 19
Midwest 102 11 4 3
South 225 56 23 15
West 133 12 14 35
Hospital bed size .01
Small 61 19 0 8
Medium 71 9 4 11
Large 518 76 45 53
Insurance type .00
Medicare 393 44 20 34
Medicaid 15 22 4 6
Private 215 32 17 25
Comorbidities – Deyo
classification
.70
None 239 42 14 24
One 254 35 23 47
Greater than one 157 27 12 21ences were likely attributable to chance alone.DISCUSSION
Endoluminal repair of thoracic aortic aneurysms has
emerged as an alternative to open repair. Improved short-
term outcomes compared with standard open repair have
been well described.1-4 While our study indicates that mor-
tality is still high for patients undergoing TEVAR at 13%,
these results may be accounted for by the introduction of
this technology during the study period of 2001 through
2005, thereby including the operator and hospital learning
curves for this technology. Further, 33.9% of these cases
were classified as either urgent or emergent, a status con-
sistently associated with higher morbidity and mortality.
The high incidence of urgent and emergent cases may
imply the need for more aggressive screening for thoracic
aortic disease by primary care physicians, allowing earlier
elective treatment of this disease. Importantly, our results
confirm in a large population a low rate of spinal cord
ischemia (0.8%), which is an often devastating complication
of open repair.
As the elderly population in the US continues to rise,
we can expect to see an increase in the number of patients
requiring treatment for thoracic aortic aneurysmal disease.4
Furthermore, an increased proportion of these patients are
expected to be minorities. Numerous reports indicate that
minorities experience higher disease-related and proce-
dure-related morbidity and mortality, a concerning find-
ing.6-19
Thus far, social and genetic investigations indicate that
race, in itself, does not determine outcome.7-20 Studies that
have determined race as an independent predictor of out-
comes often fail to control for cofounding variables or to
employ analyses adjusted for the multiple variables. A care-
ful review of this literature reveals misleading data, which is
often misinterpreted, even by those conducting the trials.
Certainly, if you look at enough variables in any two
populations, you will find statistically significant differences
that are accountable only to chance. To eliminate bias in
this study, adjustments were made for cofounding variables
and for multiple comparisons.
In this study, there were no differences in outcomes
between patients of differing ethnicity when confounding
variables were controlled, and analyses were adjusted for
multiple comparisons. These results reiterate that it is un-
likely that there are biologic differences between the races
but instead, other factors that influence procedure selection
and outcome. Reported outcome discrepancies are more
likely attributable to social and economic factors, which are
strongly tied to race and ethnicity.7-20 Differences among
the races have been well-demonstrated in terms of access to
healthcare, individual finances, insurance status, patient
attitude and perception of disease, education, and cultural
differences. The literature has also demonstrated that mi-
nority populations live in higher density locations with
lower median education and income.8 In this study, we
demonstrated differences among the races in terms of gen-
der, income, region of the country, bed size of treating
hospital, and insurance status.
JOURNAL OF VASCULAR SURGERY
Volume 51, Number 9S Murphy et al 17SSocioeconomic and payer status have been demon-
strated to directly impact outcomes in patients with, but
not limited to, appendicitis,13,14 stroke,15 cardiovascular
disease,9,14 breast cancer,8 lung cancer,12 and in those
undergoing liver transplants,12 abdominal aortic aneurysm
repair,6-8,9 coronary artery bypass grafting,14 morbid obe-
sity surgery,18,19 and orthopedic surgery.20 Insurance sta-
tus is the one socioeconomic factor linked most often with
Table II. Bivariate analysis of race classifications on outco
White
Died 78 (12%)
Non-routine discharge 315 (49%)
Central nervous system complication 8 (1%)
Spinal cord ischemia 6 (1%)
Respiratory complications 25 (4%)
Pneumonia 25 (4%)
Intubation 62 (10%)
Tracheostomy (temporary) 27 (4%)
Myocardial infarction 24 (4%)
Renal complications 25 (4%)
Acute intestinal vascular insufficiency 6 (1%)
Digestive complications 11 (2%)
Persistent fistula 2 (0%)
Transfusion 154 (24%)
Infection 23 (3.5%)
Malnutrition 13 (2%)
Peripheral angioplasty 34 (5%)
Perivascular complications 12 (2%)
Implant complications 20 (3%)
Other 13 (2%)
*No longer significant after Bonferroni adjustment.
Table III. Logistic regression for impact of race on outco
insurance classifications
White
Odds ratio
(Confidence Interval) P-v
Died 0.85 (0.41, 1.72) .64
Non-routine discharge 1.44 (0.91, 2.29) .12
Central nervous system complication 0.62 (0.07, 5.78) .67
Spinal cord ischemia 1.34 (0.15, 12.11) .79
Respiratory complications 0.71 (0.18, 2.87) .70
Pneumonia 0.39 (0.08, 1.93) .24
Intubation 1.47 (0.75, 2.87) .26
Tracheostomy (temporary) 1.05 (0.35, 3.14) .93
Myocardial infarction 1.26 (0.42, 3.79) .67
Renal complications 1.67 (0.52, 5.40) .38
Acute intestinal vascular insufficiency 1.11 (0.12, 10.42) .92
Digestive complications 0.64 (0.08, 5.24) .68
Persistent fistula
Transfusion 1.33 (0.80, 2.20) .27
Infection 3.41 (1.37, 8.47) .00
Malnutrition 1.10 (0.21, 5.90) .90
Peripheral angioplasty 1.05 (0.28, 2.89) .93
Perivascular complications 1.0 (0.19, 5.36) .99
Implant complications 0.96 (0.21, 4.40) .81
Other 0.39 (0.05, 3.21) .37
*No longer significant after Bonferroni adjustment.outcomes. Medicaid and lack of insurance are consistentlyassociated with worse medical and surgical results.6-20 Con-
versely, equal outcomes have been demonstrated among
white andAfricanAmericanmaleswith colon or lung cancer23
treated at the Department of Veterans Affairs, where patrons
are a rather homogenous population with similar socioeco-
nomic and payer status and equal access to healthcare.
Lead-time bias appears to be the driving force behind
the differences in outcomes experienced by members of
after TEVAR
Black Hispanic Other P-value
(12%) 5 (10%) 14 (19%) .303
(55%) 22 (45%) 33 (4%) .555
(1%) 0 0 .667
(1%) 0 0 .769
(3%) 3 (6%) 4 (6%) .704
(2%) 1 (2%) 6 (8%) .149
(16%) 7 (14%) 12 (17%) .066
(5%) 3 (6%) 2 (3%) .825
(6%) 2 (4%) 3 (4%) .798
(4%) 1 (2%) 3 (4%) .930
1(1%) 0 2 (3%) .432
(1%) 0 1 (1%) .770
(0%) 0 0 .875
(31%) 11 (22%) 23 (32%) .218
(9%) 0 0 .007*
(2%) 0 1 (1%) .777
(5%) 3 (6%) 3 (4%) .965
(2%) 1 (2%) 2 (3%) .960
(2%) 0 3 (4%) .508
(1%) 3 (6%) 6 (8%) .003*
after TEVAR: adjusted for cofounders and
Hispanic Other
Odds ratio
(Confidence Interval) P-value
Odds ratio
(Confidence Interval) P-value
1.49 (0.43, 5.09) .529 0.647 (0.232, 1.803) .405
2.03 (0.93, 4.47) .077 1.65 (0.77, 3.53) .197
0.52 (0.3, 8.04) .642 0.79 (0.11, 5.62) .815
0.60 (0.05, 7.52) .692 0.12 (0.13, 1.03) .053
1.05 (0.37, 3.03) .923 0.88 (0.31, 2.51) .810
0.51 (0.7, 2.14) .274 0.93 (0.14, 6.31) .933
2.35 (0.33, 16.79) .4 4.03 (0.45, 36.08) .213
4.30 (2.55, 72.54) .31 1.89 (0.28, 12.91) .516
0.19 (0, 11.08) .420
1.7 (0.71, 4.10) .235 1.02 (0.44, 2.34) .968
1.87 (0.1, 35.74) .677
1.57 (0.26, 9.37) .622 1.31 (0.23, 7.48) .764
1.70 (0.1, 29.2) .716
0.5 (0.05, 5.11) .561
0.92 (0.03, 25.05) .958 0.14 (0.1, 1.53) .106mes
12
57
1
1
3
2
17
5
6
4
1
1
32
9
2
5
2
2
1mes
alue
4
1
7
4
9
8
6
6
7
9
9
1
1
8*
9
2
8
8
8different races and socioeconomic and insurance status.
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outcomes between patients of differing insurance status
and race, it should be pointed out that it is not designed
to detect this type of bias. In the case of thoracic aneu-
rysms, lead-time bias would present with either aneu-
rysm rupture, which most often results in death prior to
intervention, or as the need for open surgical repair as
advanced aneurysm extent may prohibit TEVAR ana-
tomically. The later point was particularly true early in
the study period, when TEVAR technology was more
immature, and anatomical constraints were not so easily
navigated. This study did not include patients who died
prior to intervention or patients with more advanced
disease, who were shunted toward open thoracic aortic
repair. If the rationale of lead-time bias is correct, then
one might expect the results to be different if these
groups were included in the analysis.
In fact, when outcomes of abdominal aortic aneurysms
were evaluated by review of an earlier version (1995-2000)
of the same NIS database, including all patients with intact
or ruptured AAA undergoing open or endovascular repair,
both Medicaid and uninsured patients demonstrated worse
outcomes. Specifically, uninsured patients had a 2.3-fold
increased risk of AAA rupture compared with their privately
Table IV. Demographic variations between
insurance classifications
Variable Medicare Medicaid Private Other
P-
value
Total 491 47 289 48
Gender .00
Male gender 307 31 210 41
Surgery type .01
Emergent 101 24 72 15
Urgent 59 5 36 5
Elective 245 13 132 17
Income .00
$1K-36K 121 19 54 14
$36K-45K 107 13 57 11
$45K 244 15 173 18
Hospital region .10
Northeast 142 10 81 9
Midwest 74 4 37 5
South 181 24 95 19
West 94 9 76 15
Hospital bed size .10
Small 52 6 29 1
Medium 49 10 29 7
Large 390 31 231 40
Race .00
White 393 15 215 27
Black 44 22 32 6
Hispanic 20 4 17 8
Comorbidities – Deyo
classification
.00
None 143 22 132 22
One 200 15 105 19
Greater than one 148 10 52 7insured counterparts. Further, Medicaid and uninsuredpatients had a higher mortality after aneurysm repair in
both the elective and emergent settings. Interestingly, the
authors did not stratify results by type of repair, and cer-
tainly the higher mortality experienced by the Medicaid
and uninsured patients may have been attributable to a
higher rate of complicated aneurysms requiring open sur-
gery.7 A review of the State Inpatient database from New
Jersey, also developed under the HCUP by the AHRQ,
further confirmed that Hispanics and uninsured patients
were significantly more likely to be shunted towards open
repair compared with their white and privately insured
counterparts, a practice associated with a seven-fold in-
creased risk of mortality. The reasons for this were not
documented, but again may lie in more difficult anatomy
associated with delayed disease recognition prohibiting
EVAR or in the increased cost of this procedure for the
uninsured.8 These results were mirrored with a review of
the hospital discharge databases from New York and Flor-
ida, which demonstrated that patients with Medicaid or
those without insurance presented with AAA later and had
higher mortality rates from AAA than their insured coun-
terparts.9 In this study, Medicaid patients underwent sig-
nificantly more emergent procedures than their counter-
parts, and minorities experienced a similar trend, a subtle
hint that, in fact, lead-time bias may still underlie the
outcomes of this disease.
Lead-time bias aside, patients who underwent TEVAR
in this study had similar outcomes irrespective of race or
insurance status. Similarly, when accounting for later pre-
sentation, stage-by-stage matched patients with lung and
colon cancer exhibit similar outcomes across the different
races despite gross differences in insurance, income, and
education. While uninsured and Medicaid patients present
with more frequent AAA rupture, outcomes are the same
after treatment.9 Overall, these are encouraging findings
that suggest discrepancies in outcomes can be improved by
increasing access to healthcare. Nonetheless, while the au-
thors agree that equality in access to healthcare is an ideal
goal, it should be recognized that this may not translate to
equal outcomes. Cultural differences, patient preferences,
social perspectives, and functional status of individuals may
impact usage of even freely accessible healthcare, thereby
independently influencing outcomes.
This study does have several limitations. This is a large
retrospective observational study instead of a prospective
randomized trial. Further, the accuracy of this data depends
on complete and accurate coding. The overall rate of cod-
ing errors is improving, with 70% of hospitals included in
this database having coding error rates of 15% or less.24
Nonetheless, there has been concern about the signifi-
cant absence of racial reporting among some hospitals
included in this database and concern that Hispanics may
have been misreported as Caucasian at an unknown rate.
Clinical information that could influence patient out-
come is also missing, including detailed past medical and
surgical histories and operative information including
length of operation, estimated blood loss, hemodynamic
status, coverage of the left subclavian artery, aortic anat-
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drainage perioperatively. Finally, as discussed previously,
this study was not designed to detect lead-time bias
which appears to be the major determinant of healthcare
inequities.
Despite the limitations of this study, we were able to
demonstrate that there are significant demographic varia-
tions between the members of different races and among
Table V. Bivariate analysis for insurance classifications on
Medicare
Died 69 (14%)
Non-routine discharge 263 (54%)
Central nervous system complication 6 (1%)
Spinal cord ischemia 6 (1%)
Respiratory complications 17 (4%)
Pneumonia 21 (4%)
Intubation 53 (11%)
Myocardial infarction 20 (4%)
Tracheostomy (temporary) 20 (4%)
Renal complications 17 (4%)
Acute intestinal vascular insufficiency 2 (0%)
Digestive complications 8
Transfusion 110 (22%)
Persistent fistula 0
Infection 23 (5%)
Malnutrition 9 (2%)
Peripheral angioplasty 31 (6%)
Perivascular complications 7 (1%)
Implant complications 16 (3%)
Other 13 (3%)
*No longer significant after Bonferroni adjustment.
Table VI. Logistic regression for impact of insurance class
and race
Medicare
Odds ratio
(Confidence Interval) P-v
Died 1.71 (0.93, 3.15) .0
Non-routine cischarge 1.03 (0.68, 1.56) .8
Central nervous system complication 0.57 (0.08, 4.18) .5
Spinal cord ischemia 0.94 (0.08, 11.4) .9
Respiratory complications 0.99 (0.35, 2.82) .9
Pneumonia 0.52 (0.17, 1.64) .2
Intubation 1.38 (0.72, 2.66) .3
Tracheostomy (temporary) 2.69 (1.0, 7.36) .0
Myocardial infarction 2.67 (0.61, 4.54) .3
Renal complications 2.09 (0.73, 5.97) .1
Acute intestinal vascular insufficiency 3.95 (0.5, 31.07) .1
Digestive complications 0.99 (0.2, 4.85) .9
Persistent fistula
Transfusion 1.4 (0.88, 2.22) .1
Infection 0.74 (0.24, 2.23) .5
Malnutrition 0.91 (0.21, 3.97) .8
Peripheral angioplasty 0.98 (0.38, 2.49) .9
Perivascular complications 2.84 (0.7, 22.62) .1
Implant complications 1.61 (0.47, 5.47) .4
Other 0.24 (0.05, 1.04) .0
*No longer significant after Bonferroni adjustment.those of different insurance status. This study was unable todemonstrate any statistically significant effect of insurance
status or race on outcomes after thoracic endoluminal
aortic aneurysm repair (TEVAR) when correcting for co-
founding variables known to independently alter postoper-
ative outcomes. Emphasis should therefore be placed on
early diagnosis, identifying and eliminating any potential
lead-time bias in this disease, and making this advanced
technology accessible for all patients regardless of ethnicity
omes after TEVAR
dicaid Private Other P-value
(19%) 36 (13%) 3 (6%) .305
(47%) 125 (43%) 17 (35%) .009*
0 3 (1%) 0 .761
0 1 (0.3%) 0 .454
(6%) 13 (5%) 2 (4%) .740
(9%) 8 (3%) 1 (2%) .233
(28%) 28 (10%) 10 (21%) .059
(6%) 11 (4%) 1 (2%) .756
(6%) 12 (4%) 2 (4%) .903
(2%) 11 (4%) 4 (8%) .357
0 7 (2%) 0 .039*
0 5 0 .655
(36%) 83 (29%) 4 (8%) .003
0 2 (1%) 0 .255
(4%) 7 (2%) 0 .204
(2%) 5 (2%) 1 (2%) .996
0 11 (4%) 3 (6%) .164
(4%) 7 (2%) 1 (2%) .501
0 7 (2.4%) 2 (4%) .540
(2%) 6 (2%) 3 (6%) .415
tion on outcomes after TEVAR: adjusted for cofounders
Medicaid Other
Odds ratio
(Confidence Interval) P-value
Odds ratio
(Confidence Interval) P-value
0.71 (0.29, 1.78) .469 2.88 (0.77, 10.77) .117
0.82 (0.40, 1.66) .656 1.26 (0.65, 2.47) .494
0.51 (0.11, 2.30) .378 0.9 (0.18, 4.46) .9
0.23 (0.05, 1.05) .058 1.33 (0.14, 12.52) .806
0.32 (0.13, 0.77) .011* 1.1 (0.25, 3.44) .876
0.56 (0.13, 2.5) .450 0.74 (0.15, 3.73) .718
0.81 (0.15, 4.37) .806 1.6 (0.16, 15.75) .686
1.84 (0.21, 16.18) .584 0.39 (0.11, 1.42) .153
0.97 (0.46, 2.05) .93 1.63 (0.72, 3.67) .243
0.78 (0.13, 4.86) .793
0.65 (0.06, 7.26) .723 0.69 (0.07, 6.89) .754
0.62 (0.14, 2.81) .537
0.59 (0.09, 4.09) .592 1.18 (0.13, 10.5) .883
0.53 (0.09, 3.11) .48
1.8 (0.15, 22.34) .648 0.57 (0.1, 3.16) .521outc
Me
9
22
3
4
13
3
3
1
17
2
1
2
1ifica
alue
83
93
77
58
87
64
35
54
18
67
92
89
54
89
97
62
46
49
56or insurance status.
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